Background
==========

Cytomegalovirus is member of the herpesviridae family and usually causes asymptomatic infections. It remains latent and may reactivate when the host has poor immune responses leading to life threatening infection. Cytomegalovirus (CMV) is a known cause of severe central nervous system (CNS) infection among immunosuppressed patients especially among those infected with human immunodeficiency virus. CNS infections reported in the immunocompetent hosts due to CMV include encephalitis, meningitis, myelitis and the combinations of any of the above \[[@B1]\]. Although randomized trials are lacking, physicians generally tend to use antiviral treatment including ganciclovir and valganciclovir for severe CMV infections. Use of polymerase chain reaction of CSF for CMV has been reccommended for diagnosis of CNS infection \[[@B2]\].

Acute transverse myelitis is a focal inflammatory disorder of the spinal cord with sensory, motor and autonomic dysfunction \[[@B3]\]. Cytomegalovirus has been described rarely as a aetiological agent in immunocompetent adults presenting with transverse myelitis with only ten cases described previously \[[@B4]-[@B13]\]. Infact, any form of severe infection with cytomegalovirus is rare \[[@B14]\]. Out of the ten, only five cases describe abnormalities in the magnetic resonance imaging (MRI) of spinal cord in CMV associated transverse myelitis (Table [1](#T1){ref-type="table"}). Two reports describe confirmation of CMV infection with detection of CMV deoxyribonucleic acid (DNA) in the serum by polymerase chain reaction (PCR) while one report describe confirmed CMV antigenaemia. There were no reported cases of CMV PCR positivity in cerebrospinal fluid. We describe a immunocompetent adult who had clinical features, neuroimaging findings and CSF analysis compatible with transverse myelitis where CMV DNA was detected in CSF.

###### 

The comparison of CSF analysis, MRI appearance, CMV serology and PCR of reported cases of CMV associated transverse myelitis in non-immunocompromised patients

  **Case report (year) First author**   **CSF protein mg/l**   **CSF White cells/mm**^**3**^   **Blood serology**   **CSF serology**   **CSF PCR**   **Blood PCR**          **MRI findings**
  ------------------------------------- ---------------------- ------------------------------- -------------------- ------------------ ------------- ---------------------- --------------------------
  Our Patient (2011)                    300                    350 (L-92%)                     Negative             Negative           Positive      ND                     T1 mild swelling (C2-C5)
                                                                                                                                                                            T2 hyperintensity
                                                                                                                                                                            No contrast enhancement
  1 (2006) Ben Abdelhafidh N            430                    15 (L-80%)                      Positive             ND                 Negative      Negative               T1 hypointensity
                                                                                                                                                                            T2 hyperintensity
                                                                                                                                                                            No contrast enhancement
  2 (2005) Rigamonti A                  370                    11 (L-85%)                      Positive             Positive           Negative      Negative               T1 signal abnormality
                                                                                                                                                                            T2 hyperintensity
                                                                                                                                                                            Contrast enhancement
  3 (2003) Fux CA                       480                    29 (M-95%)                      Positive             Negative           Negative      CMV Antigen positive   Negative
  4 (2002) Karacostas D                 150                    0                               Positive             Positive           Negative      Positive               T1 Normal
                                                                                                                                                                            T2 hyperintensity
                                                                                                                                                                            No contrast enhancement
  5 (1999) Giobbia M                    1240                   3(L-100%)                       Positive             negative           Negative      positive               T2 hyperintensity
  6 (1995) Baig SM                      1650                   230(M-95%)                      Positive             ND                 ND            ND                     Negative
  7 (1993) Miles C                      1700                   200(PMN-62%)                    Positive             ND                 ND            ND                     Negative
  8 (1993) Tobita M                     1020                   104                             Positive             Positive           ND            ND                     T2 hyperintensity
  9 (1986) Tyler KL                     1400                   226 (M-76%)                     Positive             ND                 ND            ND                     ND
  10(1976) Kabins S                     7200                   3200 (PMN-100%)                 Positive             ND                 ND            ND                     ND

ND-not done.

Majority of the case show CSF pleocytosis with lymphocyte predominance and T 2 signal hyper intensity in the MRI.

Transverse myelitis diagnosis criteria
======================================

Bilateral (not necessarily symmetric) sensorimotor and autonomic spinal cord dysfunction

Clearly defined sensory level

Progression to nadir of clinical deficits between 4 hours and 21 days after symptom onset

Demonstration of spinal cord inflammation: cerebrospinal fluid pleocytosis or elevated IgG index, or MRI revealing a gadolinium-enhancing cord lesion

Exclusion of compressive, postradiation, neoplastic, and vascular causes

Case presentation
=================

A forty year old previously healthy Sri Lankan male presented with acute onset bilateral leg weakness which was progressive over two days following a brief febrile illness of three days. He did not give any history of trauma nor there was any history of tuberculosis. Initially he did not have urinary retention nor there was any sensory symptoms. He did not complain of shortness of breathing.

On examination he was found to have asymmetric flaccid paralysis of bilateral lower limbs with power grade one to two. Reflexes were diminished bilaterally and Babinski sign was equivocal. Examination of optic fundi and cranial nerves were normal. There was no demonstrable sensory level and joint position sense was initially preserved. Upper limbs were neurologically normal. Respiratory movements and sphincter function were preserved. Depending on initial findings a clinical diagnosis of Guillain-Barré syndrome was suspected and he was closely observed for the development of respiratory paralysis with monitoring of forced vital capacity and oxygen saturation.

On the fifth day of onset of symptoms his weakness worsened with additional flaccid paralysis of upper limbs and neck muscles. He was catheterized for acute retention of urine. Patient was urgently transferred to a high dependency unit but he did not develop respiratory paralysis necessitating ventilator support. Later he developed bilateral spastic paraparesis and positive Babinski sign with mild paraesthesia of lower limbs. But he did not develop a definite sensory level at anytime during the course of his illness.

A nerve conduction study failed to show demyelination or axonal loss. Magnetic resonance imaging study of the spine showed hyperintensity of central portion of mid cervical cord from C 2 to C 5 level in T2 weighted and FLAIR images (Figure [1](#F1){ref-type="fig"}) There was mild swelling of cervical cord without significant change of signal intensity on T1 weighted image (Figure [2](#F2){ref-type="fig"}).

![T2 weighted image showing hyperintensity of the central portion of the mid cervical cord (arrow).](1756-0500-5-364-1){#F1}

![T1 weighted image showing mild swelling of mid cervical cord (arrow).](1756-0500-5-364-2){#F2}

Basic investigations were as follows; Na^+^ 139 mmol/l, K^+^-4.2 mmol/l, Serum creatinine-62 μmol/l, blood urea 8.7 mmol/l, White cell count 5000/mm^3^(N-76,L-18), platelet count 17500/mm^3^. Haemoglobin 9.3 g/dl, AST-51u/l, ALT-74u/l, Bilirubin 12 μmol/l, ESR-12 mm/hr, CRP-0.4 mg/dl, VDRL-negative, Fasting blood sugar 5.4 mmol/l.

Cerebrospinal fluid analysis done on the tenth day after onset of weakness was suggestive of a viral CNS infection with a protein content of 300 mg/l, glcose 4.3 mmol/l(RBS 10.9 mmol/l) and a leukocyte count of 350/mm^3^(92% lymphocytes). CSF infectious screen was positive for cytomegalovirus PCR(sensitivity more than 100copies/ml). This test was repeated and result was confirmed. Cytomegalovirus IgG and IgM were not detected in CSF. Polymerase chain reaction of CSF for herpes simplex virus(HSV) and Japanese encephalitis virus(JEV) were negative. Oligoclonal bands were not detected in CSF.

Considering the overall clinical picture, a working diagnosis of CMV associated transverse myelitis was made. Immunoglobulin levels and lymphocyte subset analysis failed to identify any immunodeficiency while HIV serology was negative.

Patient received treatment with intravenous ganciclovir for a duration of 21 days starting on the 10th day of illness. He was also given maximal supportive care with physiotherapy and psychological support. A second CSF analysis done 22 days after the onset of symptoms revealed no cells and protein content of 390 mg/l. (CSF glucose 3.6 mmol/l RBS-6.5 mmol/l) Repeated CMV serology in blood, CSF and CSF PCR for CMV were negative on the 22nd day of illness.

One month after the onset of symptoms the upper limb power was improved (grade 5) but the lower limb power remained grade 3. He was transferred to a long term rehabilitation facility.

Conclusions
===========

The findings in our patient are suggestive of acute transverse myelitis involving spinal segments C3 to C5. According to the proposed diagnosis criteria for Transverse myelitis \[[@B3]\] our patient had evidence of spinal cord inflammation evidenced by CSF pleocytosis and MRI appearance. Although a clear sensory level was absent, he had sensory, motor and autonomic dysfunction attributable to the spinal cord, bilateral involvement, progression to nadir between 4 hours to 21 days after symptom onset and absence of compressive lesions.

Patient's clinical history was compatible with acute cytomegalovirus infection. Polymerase chain reaction has been found to be the most reliable method for the CMV related CNS infections \[[@B6]\]. While cytomegalovirus is an identified cause of myelitis in immunocompromised hosts, it is rare in the immunocompetent people with only few published case reports (Table [1](#T1){ref-type="table"}). Cytomegalovirus PCR has demonstrated the presence of CMV DNA in blood in only two reported cases of CMV associated transverse myelitis in the immunocompetent patients \[[@B7],[@B8]\]. In other immunocompetent patients with CMV transverse myelitis, either PCR was not done or was negative. All ten patients had positive serology for CMV antibody while in this patient serology was negative.

Five patients had their CSF tested for CMV DNA by PCR and all were negative. Therefore our patient is the first reported case of CMV DNA positivity in CSF among all immunocompetent patients with CMV transverse myelitis. Absence of CMV DNA in CSF in previous cases has been considered to favour immune mediated rather than direct virus induced injury to the cord \[[@B5],[@B6]\]. The presence of CMV DNA in CSF while serology remained negative may indicate direct virus induced injury has to be considered in the pathogenesis of CMV transverse myelitis. The reason for negativity of CMV antibodies in our patient could be either due to low sensitivity of the serological test or early treatment leading to destruction of virus before an immunological response is mounted.

Out of the ten patients MRI findings were abnormal in five patients, while others either had normal MRI appearances or MRI was not performed. Commonest MRI finding was signal hyperintensity in T2 sequences. Other documented MRI findings include T1 hypointensity as well as hyper intensity. Contrast enhancement of the spinal cord was documented only in a single case report \[[@B5]\].

This case emphasizes the fact that CMV should be considered as an aetiological agent in patients presenting with a clinical syndrome suggestive of transverse myelitis even though they are immunocompetent. Cytomegalovirus DNA detection in CSF and MRI appearance can help in the diagnosis of CMV transverse myelitis. Although randomised trials are lacking, ganciclovir can be useful in the management of CMV transverse myelitis.
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